Kim has over 30 years of experience leading development organizations within large and small companies and has demonstrated success in negotiations with worldwide regulatory agencies resulting in multiple regulatory product approvals. She has extensive experience with global clinical and regulatory strategies for medicinal and aesthetic drugs and device products through all phases of development and has also received approval for Orphan Drug and Fast Track designations for rare disease development programs. Kim successfully built and led cross functional teams for development of pharmaceutical products in various therapeutic areas including dermatology, respiratory, cardiovascular, hormone replacement, and autoimmune disorders.
Sign up to view 0 direct reports
Get started